SecBot SecBot
SECBOTREPLAY Home › Report › PVLA

PVLA · Palvella Therapeutics announced it will report its full year 2025…

Palvella Therapeutics Inc. · PRESS-RELEASE filed Mar 24, 2026 at 07:30 ET

At the news

NEUTRALIMPACT 3/10

PRESS-RELEASE filed Mar 24, 2026 at 07:30 ET

Palvella Therapeutics announced it will report its full year 2025 financial results on March 31, 2026, followed by a conference call to discuss the results and provide a corporate update. The press release contains no actual financial data, only logistical details about the upcoming earnings announcement.

  • Palvella Therapeutics will report full year 2025 financial results on March 31, 2026, before market open.
  • Management will host a conference call at 8:30 a.m. ET on March 31, 2026, to discuss results and provide a corporate update.
  • No financial results, guidance, or operational updates were disclosed in this release.
  • Company remains in clinical-stage development with no FDA-approved therapies yet.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access